MENU
+Compare
EDTXF
Stock ticker: OTC
AS OF
Dec 23 closing price
Price
$0.93
Change
-$0.00 (-0.00%)
Capitalization
268.29M

EDTXF Spectral Medical Inc. Forecast, Technical & Fundamental Analysis

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic... Show more

EDTXF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for EDTXF with price predictions
Dec 24, 2025

EDTXF's Indicator enters downward trend

The Aroon Indicator for EDTXF entered a downward trend on December 09, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 171 similar instances where the Aroon Indicator formed such a pattern. In of the 171 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EDTXF as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDTXF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 75 cases where EDTXF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EDTXF just turned positive on December 05, 2025. Looking at past instances where EDTXF's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EDTXF advanced for three days, in of 153 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EDTXF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (12.609). P/E Ratio (0.000) is within average values for comparable stocks, (131.408). EDTXF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.862). EDTXF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). EDTXF's P/S Ratio (133.333) is very high in comparison to the industry average of (11.789).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
EDTXF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

EDTXF is expected to report earnings to fall 66.67% to 0 cents per share on March 26

Spectral Medical Inc. EDTXF Stock Earnings Reports
Q4'25
Est.
$-0.01
Q4'23
Missed
by $0.02
Q3'23
Est.
$-0.01
Q2'23
Est.
$-0.01
Q1'23
Est.
$-0.01
The last earnings report on March 28 showed earnings per share of -2 cents, missing the estimate of 0 cents. With 27.67K shares outstanding, the current market capitalization sits at 268.29M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
135 - 2 The West Mall
Phone
+1 416 626-3233
Employees
32
Web
https://www.spectraldx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OLVCX20.450.08
+0.39%
JPMorgan Large Cap Value C
VDMCX10.520.04
+0.38%
Virtus KAR Developing Markets C
ASQIX18.190.06
+0.33%
American Century Small Company Inv
SLRYX42.600.12
+0.28%
SEI Large Cap Growth Y (SIMT)
NBMOX52.260.13
+0.25%
Neuberger Small Cap Growth Tr

EDTXF and Stocks

Correlation & Price change

A.I.dvisor tells us that EDTXF and ASAPF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDTXF and ASAPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDTXF
1D Price
Change %
EDTXF100%
N/A
ASAPF - EDTXF
22%
Poorly correlated
+1.35%
KSRBF - EDTXF
21%
Poorly correlated
N/A
TDSGF - EDTXF
20%
Poorly correlated
N/A
FSPKF - EDTXF
3%
Poorly correlated
N/A
DSRLF - EDTXF
3%
Poorly correlated
+2.34%
More